Polyps Clinical Trials

68 recruitingLast updated: June 18, 2026

There are 68 actively recruiting polyps clinical trials across 34 countries. Studies span Not Applicable, Phase 3, Phase 4, Phase 2, Early Phase 1, Phase 1. Top locations include Chicago, Illinois, United States, Ghent, Belgium, Leuven, Belgium. Updated daily from ClinicalTrials.gov.


Polyps Trials at a Glance

68 actively recruiting trials for polyps are listed on ClinicalTrialsFinder across 6 cities in 34 countries. The largest study group is Not Applicable with 24 trials, with the heaviest enrollment activity in Chicago, Ghent, and Leuven. Lead sponsors running polyps studies include AstraZeneca, Sanofi, and University Hospital, Lille.

Treatments under study

About Polyps Clinical Trials

Looking for clinical trials for Polyps? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Polyps trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Polyps clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 68 trials

Recruiting
Phase 1

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

Colorectal CarcinomaFamilial Adenomatous PolyposisColorectal Adenomatous Polyp+1 more
National Cancer Institute (NCI)36 enrolled5 locationsNCT05630794
Recruiting

A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients

Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca200 enrolled16 locationsNCT07446738
Recruiting
Not Applicable

Testing of GripTract-GI Endoscopic Tissue Manipulator for Use During Complex Endoscopic Polypectomies in the Colon

Polyps Colorectal
Actuated Medical, Inc.30 enrolled1 locationNCT06015607
Recruiting
Phase 4

Biologics in Chronic Rhinosinusitis With Nasal Polyposis

Chronic SinusitisNasal Polyps
Medical University of South Carolina504 enrolled1 locationNCT06824649
Recruiting
Phase 3

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Eli Lilly and Company510 enrolled194 locationsNCT06338995
Recruiting

ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia

AsthmaChronic Rhinosinusitis With Nasal Polyps (CRSwNP)
AstraZeneca110 enrolled11 locationsNCT07399665
Recruiting
Phase 3

A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab

Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca230 enrolled1 locationNCT07520162
Recruiting
Not Applicable

3D Printing to Improve Nasal Irrigation Outcome

Chronic Rhinosinusitis With Nasal PolypsChronic Rhinosinusitis Without Nasal Polyps
Ohio State University200 enrolled1 locationNCT06118554
Recruiting
Phase 3

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps
Sanofi210 enrolled112 locationsNCT06834360
Recruiting
Not Applicable

BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry

Nasal PolypsRhinosinusitis Chronic
University Hospital, Lille900 enrolled2 locationsNCT06501807
Recruiting
Not Applicable

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

Colonic Polyps
Capso Vision, Inc.330 enrolled11 locationsNCT07089615
Recruiting
Not Applicable

Polysomnographic Findings in Nasal Polyposis

Obstructive Sleep ApneaChronic Rhinosinusitis With Nasal Polyps
University Hospital, Lille30 enrolled1 locationNCT03725956
Recruiting
Phase 2

Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study

Chronic Rhinosinusitis With Nasal Polyps
Sanofi64 enrolled24 locationsNCT06914908
Recruiting
Phase 3

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps
Sanofi210 enrolled121 locationsNCT06834347
Recruiting
Not Applicable

Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain140 enrolled1 locationNCT06776042
Recruiting
Not Applicable

A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size

Artificial Intelligence (AI)CRC (Colorectal Cancer)Colonic Polyps
Chinese University of Hong Kong278 enrolled1 locationNCT06957015
Recruiting
Phase 3

A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab

Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca180 enrolled45 locationsNCT06706817
Recruiting
Not Applicable

The Impact of Image-Assisted Colonoscope on Patient Experience, Physician Workload, and Examination Quality

Colorectal Cancer ScreeningColonic Polyps/Colonoscopy/Colorectal NeoplasmsDifficult Colonoscopy+1 more
DONG WU200 enrolled1 locationNCT07541924
Recruiting
Not Applicable

Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial

Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
Tang-Du Hospital192 enrolled1 locationNCT07498374
Recruiting
Phase 3

Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps

Chronic Rhinosinusitis Without Nasal Polyps
Optinose US Inc.84 enrolled21 locationsNCT06850805